Management of Recurrent Hepatitis C in Orthotopic Liver Transplant Recipients

• Autores: Geeta S. Karnik, Kirti Shetty
• Localización: Infectious disease clinics of North America, ISSN 0891-5520, Vol. 27, Nº. 2, 2013, págs. 285-304
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • End-stage liver disease and hepatocellular carcinoma from chronic hepatitis C are the most common indications for orthotopic liver transplantation and the incidence of both are projected to increase over the next decade. Recurrent hepatitis C virus infection of the allograft is associated with an accelerated progression to cirrhosis, graft loss, and death. This article presents an overview of the natural history of hepatitis C virus recurrence in liver transplant recipients and guidance on optimal management strategies.